Vivo Opportunity, LLC, Director, Ten Percent Owner at Sierra Oncology, holds 8.42M shares in Soleno Therapeutics (Ticker: SLNO), holds 6.66M shares in Terns Pharmaceuticals (Ticker: TERN), holds 0.00 shares in Sierra Oncology (Ticker: SRRA). Most recently, Vivo Opportunity, LLC Bought ― shares of Soleno Therapeutics on Oct 04, 2023 for an estimated value of 13.04M.